
Humana HUM
€ 333.19
0.09%
Humana EV/EBITDA | HUM
EV/EBITDA Jährlich Humana
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 14.7 | 17.8 | 14.8 | 19.3 | 21.3 | 9.67 | - | - | - | - | - | - | - | - | - | 7.15 | 6.2 | 11.4 | -1.32 | - |
Alle Zahlen in USD-Währung
Indikatorenreichweite aus Jahresberichten
| Höchstwert | Mindestwert | Durchschnitt |
|---|---|---|
| 21.3 | -1.32 | 12.1 |
EV/EBITDA anderer Aktien in der Gesundheitsvorsorge
| Name | EV/EBITDA | Preis | % 24h | Marktkapitalisierung | Land | |
|---|---|---|---|---|---|---|
|
Cigna Corporation
CI
|
15.4 | $ 280.45 | 0.04 % | $ 73.9 B | ||
|
Centene Corporation
CNC
|
26.4 | $ 66.01 | 0.68 % | $ 32.6 B | ||
|
CVS Health Corporation
CVS
|
28.7 | $ 91.72 | 0.95 % | $ 116 B | ||
|
Molina Healthcare
MOH
|
14.3 | $ 202.22 | 4.83 % | $ 10.7 B | ||
|
NovoCure Limited
NVCR
|
-13.6 | $ 16.22 | 0.43 % | $ 1.81 B | ||
|
UnitedHealth Group Inc.
UNH
|
19.3 | $ 375.26 | 0.03 % | $ 341 B | ||
|
Triple-S Management Corporation
GTS
|
79.5 | - | 0.28 % | $ 847 M | ||
|
Magellan Health, Inc.
MGLN
|
16.1 | - | -0.19 % | $ 2.49 B | ||
|
Anthem
ANTM
|
7.77 | - | -2.32 % | $ 107 B |